Paladin Partners »

Mink Therapeutics shares owned by Paladin Partners

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Paladin Partners from 13F filings

Historical chart of Paladin Partners investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Paladin Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Paladin Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $11k 1.0k 10.53
2025-12-31 $11k 1.0k 11.15

More positions owned by Paladin Partners

Ishares Russell 1000 Etf (IWB)
State Street Spdr S&p 500 Etf (SPY)
NVIDIA Corporation (NVDA)
Ishares Russell 1000 Value Etf (IWD)
Vanguard Total Stock Market Etf (VTI)
State Street Spdr Bloomberg Convertible Securities Etf (CWB)
Vanguard Total International Bond Etf (BNDX)
Ishares Iboxx $ High Yield Corporate Bond Etf (HYG)
Ishares Msci Eafe Etf (EFA)
Ishares Core U.s. Aggregate Bond Etf (AGG)
Apple (AAPL)
Ishares Trust Ishares 0-1 Year Treasury Bond Etf (SHV)
Berkshire Hathaway Del Cl B New (BRK.B)
State Street Energy Select Sector Spdr Etf (XLE)
Ishares Russell Midcap Etf (IWR)

View all positions for Paladin Partners

Top funds holding Mink Therapeutics

Vanguard Group
Vanguard Capital Management
Geode Capital Management
Longbow Finance SA
UBS Group
Vanguard Fiduciary Trust
BlackRock
Steward Partners Investment Advisory
Paladin Partners
Annis Gardner Whiting Capital Advisors
Tower Research Capital
Covestor
Advisor Group Holdings
Morgan Stanley
Citigroup

View all funds holding Mink Therapeutics